Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewThe cannabinoid acids, analogs and endogenous counterpartsPeroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cellsCytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyPeroxisome proliferator activated receptor-γ and traumatic brain injury.Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts.Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Molecular mechanisms of denbinobin-induced anti-tumorigenesis effect in colon cancer cells.Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancerRegio- and stereospecific syntheses and nitric oxide donor properties of (E)-9- and (E)-10-nitrooctadec-9-enoic acidsPeroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARgamma Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin J(2).Prevention of methylmercury-induced mitochondrial depolarization, glutathione depletion and cell death by 15-deoxy-delta-12,14-prostaglandin J(2).Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.Transcriptional regulation of T helper 17 cell differentiationPPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells.Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells.ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells.Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene-gene interaction with asthma risk in a Chinese adults population.Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion.Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritisCyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives.Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis.The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action.Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
P2860
Q21245560-1D8FE23E-69FB-41B3-84EF-F08A1288E7E9Q24561401-06443FCF-6784-44A8-9F8E-56CD2641B9F2Q27009735-61E52975-19D4-4C29-A3FA-2F2A2268BA22Q28573588-1BA72526-502C-424F-8671-620E9DFD02FAQ31093216-ABB97C49-1685-455B-BBB5-F925471CD001Q33318963-E0E7BF44-297E-4BC3-A274-73B630FFF1B5Q33428310-22A858E5-4116-45ED-8E41-BF5E7E83A94EQ33458922-CECB31C1-9A6B-40BF-8AB1-F247F05452EDQ34237948-9539468C-13C0-40F9-B8E4-7521BE48CEF2Q34271250-27831B33-AC21-4BB5-95B3-ACE6B064375CQ34365179-CD7E452F-8939-4242-A6DD-AA92B2A5C79BQ34814329-92895438-6DBD-487F-BDA5-93E38218D007Q34933261-9E994BCC-A5B9-43DA-9CB6-586D94C35AACQ35010953-98C53FE6-5DFA-432C-A50A-55FE7E73D7F7Q35956157-97A62446-DC56-4DD9-89B4-5975DED0E6ACQ36245143-FDE27483-F20E-4907-816E-1DADF90DEE5FQ36347304-4F97192F-2FFA-4631-8A84-53411ADB18ABQ37079967-AB824603-2007-49E5-A2CD-0212FBA7DBF9Q37125988-BDE80272-1530-463E-A116-DA9C27C12D48Q37196268-AD0B1EBC-6F32-42C6-91AD-8A5092BADAD1Q37222698-4D287B2C-1364-420C-9378-0D94BAF0A3DEQ37760477-4BB3163E-A395-41F5-AF4D-9EE7CBB2E1AFQ38620031-8893CD03-CA06-4238-8216-9FCB4D82168FQ38795202-34A6DA6C-9AD8-4996-A45E-9A9ADC42913EQ39021000-55AA5AE6-EB59-4F15-AA93-7322478A64CBQ39329694-C53B2E9C-A451-474A-9A0A-9AE5AAB09E82Q39731280-BAD07399-CD15-4E63-BE80-F5A269626818Q40037006-7B7F99C7-82BC-4C9E-A87D-B6E2707D1E7DQ40357493-D814DA55-639D-4042-ADB8-BA898DA340C2Q41563936-A72ECF01-1048-41AF-8A3D-375BA22C5913Q41868953-DD299E66-A7B3-4CDA-AD09-C66333BF258FQ41888146-D4A02A84-39EE-4BFA-83FB-6C3F755312BCQ42345064-9AAE2B74-8153-4288-A631-6E7118DF4564Q42414904-33820625-6309-4774-8D8D-150B38DC90AAQ43040958-4D015FC4-2487-4A11-B92D-FA4650EF02DBQ43287595-7780BA18-4BEB-495E-A626-114EEE0EF610Q45023576-9244967C-E293-44AB-9E57-413DDB49D138Q45226885-F46F56C6-8F7F-41B0-B55C-1DECC99BF8B7Q48186804-4BA4688E-D1D8-4117-9A42-69B4E3723117Q53302209-229785E3-9A2E-42A9-AFF5-E25FD6382300
P2860
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@ast
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@en
type
label
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@ast
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@en
prefLabel
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@ast
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@en
P1476
Peroxisome proliferator-activa ...... ulators of cell proliferation.
@en
P2093
Hye-Kyung Na
Young-Joon Surh
P304
P356
10.1016/S0006-2952(03)00488-X
P407
P577
2003-10-01T00:00:00Z